Reshma P. Shetty, See remarks at Ginkgo Bioworks Holdings, Inc. (DNA), sold 75,300 shares at $2.04 ($152K) on 2023-09-13, disclosed to the SEC on 2023-09-15.
Scheduled sale ($152k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.04 | 37,650 | $77K | 50.5% |
| 2 | $2.00 | 37,650 | $75K | 49.5% |
| Total | $2.02 avg | 75,300 | $152K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $133K | — | Filing → |
| DNA | SELL | 2023-12-15 | $173K | — | Filing → |
| DNA | SELL | 2023-12-08 | $99K | — | Filing → |